Huifeng Bio-Pharmaceutical Technology, Inc. (HFGB.OB) Secures $3.9M to Build Diosmin Plant, Massively Expanding Output to Meet Global Demand
Huifeng Bio-Pharmaceutical, www.hfgb.cn – the Chinese producer of flavonoids like rutin and other plant extracts/concentrated pharmaceutical raw materials, reported today entry into a $3.9M financing and construction agreement with Xi'an Jucheng Investment & Consulting Co., Ltd. (Jucheng). Jucheng is fully compliant with extant PRC laws and will provide $3.9M in financing under the agreement for the construction of a 500 ton/year Diosmin (another flavonoid) plant, designed from the ground up around the Chinese COS Standard. Subsequently, HFGB will issue 6.5M shares of its restricted common stock in consideration, 1.5M of which will stay restricted until HFGB approves the completed facility…